|Other Names||Vesicle transport protein GOT1B, Germ cell tumor 2, Golgi transport 1 homolog B, Putative NF-kappa-B-activating protein 470, hGOT1a, GOLT1B, GCT2, GOT1A|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13094b was selected from the C-term region of GOT1B. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May be involved in fusion of ER-derived transport vesicles with the Golgi complex.|
|Cellular Location||Golgi apparatus membrane; Multi-pass membrane protein|
|Tissue Location||Widely expressed. Tends to be up-regulated in seminomas compared to normal testis|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
GOT1B may be involved in fusion of ER-derived transport vesicles with the Golgi complex.
Lamesch, P., et al. Genomics 89(3):307-315(2007)Clark, H.F., et al. Genome Res. 13(10):2265-2270(2003)Matsuda, A., et al. Oncogene 22(21):3307-3318(2003)Bourdon, V., et al. Cancer Res. 62(21):6218-6223(2002)Simpson, J.C., et al. EMBO Rep. 1(3):287-292(2000)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.